Kate L. Lowe

1.2k total citations
14 papers, 589 citations indexed

About

Kate L. Lowe is a scholar working on Oncology, Surgery and Hematology. According to data from OpenAlex, Kate L. Lowe has authored 14 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Surgery and 4 papers in Hematology. Recurrent topics in Kate L. Lowe's work include Lymphatic System and Diseases (8 papers), Lymphatic Disorders and Treatments (4 papers) and Platelet Disorders and Treatments (3 papers). Kate L. Lowe is often cited by papers focused on Lymphatic System and Diseases (8 papers), Lymphatic Disorders and Treatments (4 papers) and Platelet Disorders and Treatments (3 papers). Kate L. Lowe collaborates with scholars based in United Kingdom, United States and Germany. Kate L. Lowe's co-authors include Steve P. Watson, Leyre Navarro‐Núñez, Brenda Finney, Francesca Barone, C Bénézech, Christopher D. Buckley, Craig E. Hughes, Bernhard Nieswandt, Bent K. Jakobsen and Rupert Kenefeck and has published in prestigious journals such as Blood, Arteriosclerosis Thrombosis and Vascular Biology and European Journal of Immunology.

In The Last Decade

Kate L. Lowe

14 papers receiving 579 citations

Peers

Kate L. Lowe
Hina Desai United States
Beth A. Markens United States
Abdo Abou-Slaybi United States
Thomas C. Beck United States
K S Song South Korea
Kate L. Lowe
Citations per year, relative to Kate L. Lowe Kate L. Lowe (= 1×) peers Nagaharu Tsukiji

Countries citing papers authored by Kate L. Lowe

Since Specialization
Citations

This map shows the geographic impact of Kate L. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate L. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate L. Lowe more than expected).

Fields of papers citing papers by Kate L. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kate L. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate L. Lowe. The network helps show where Kate L. Lowe may publish in the future.

Co-authorship network of co-authors of Kate L. Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of Kate L. Lowe. A scholar is included among the top collaborators of Kate L. Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kate L. Lowe. Kate L. Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Haining, Elizabeth J., Kate L. Lowe, Surasak Wichaiyo, et al.. (2020). Lymphatic blood filling in CLEC-2-deficient mouse models. Platelets. 32(3). 352–367. 17 indexed citations
2.
Lowe, Kate L., David K. Cole, Rupert Kenefeck, et al.. (2019). Novel TCR-based biologics: mobilising T cells to warm ‘cold’ tumours. Cancer Treatment Reviews. 77. 35–43. 64 indexed citations
3.
Ely, Lauren K., Marco Lolicato, Tovo David, et al.. (2018). Structural Basis for Activity and Specificity of an Anticoagulant Anti-FXIa Monoclonal Antibody and a Reversal Agent. Structure. 26(2). 187–198.e4. 7 indexed citations
4.
Lax, Siân, Julie Rayes, Surasak Wichaiyo, et al.. (2017). Platelet CLEC-2 protects against lung injury via effects of its ligand podoplanin on inflammatory alveolar macrophages in the mouse. American Journal of Physiology-Lung Cellular and Molecular Physiology. 313(6). L1016–L1029. 54 indexed citations
5.
Wilson, Stephen J., Kate L. Lowe, Michael P. Bokoch, et al.. (2017). Abstract 437: Endothelial Cell Gene Expression in Hypertensive Mice. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1). 1 indexed citations
6.
Pollitt, Alice Y., et al.. (2015). Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling. Thrombosis and Haemostasis. 113(5). 1109–1120. 21 indexed citations
7.
Lowe, Kate L., Brenda Finney, Carsten Deppermann, et al.. (2015). Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development. Blood. 125(24). 3769–3777. 71 indexed citations
8.
Lowe, Kate L., Leyre Navarro‐Núñez, C Bénézech, et al.. (2015). The expression of mouse CLEC‐2 on leucocyte subsets varies according to their anatomical location and inflammatory state. European Journal of Immunology. 45(9). 2484–2493. 36 indexed citations
9.
Bénézech, C, Saba Nayar, Brenda Finney, et al.. (2014). CLEC-2 is required for development and maintenance of lymph nodes. Blood. 123(20). 3200–3207. 59 indexed citations
10.
Hughes, Craig E., Brenda Finney, Frank Köentgen, Kate L. Lowe, & Steve P. Watson. (2014). The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets. Blood. 125(1). 144–154. 33 indexed citations
11.
Watson, Steve P., Kate L. Lowe, & Brenda Finney. (2013). Platelets in Lymph Vessel Development and Integrity. Advances in anatomy, embryology and cell biology. 214. 93–105. 14 indexed citations
12.
Borgognone, Alessandra, Kate L. Lowe, Steve P. Watson, & Melanie Madhani. (2013). Natriuretic peptides induce weak VASP phosphorylation at Serine 239 in platelets. Platelets. 25(1). 1–7. 11 indexed citations
13.
Lowe, Kate L., Leyre Navarro‐Núñez, & Steve P. Watson. (2012). Platelet CLEC-2 and podoplanin in cancer metastasis. Thrombosis Research. 129. S30–S37. 90 indexed citations
14.
Finney, Brenda, Edina Schweighoffer, Leyre Navarro‐Núñez, et al.. (2011). CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood. 119(7). 1747–1756. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026